Biomerica Inc. (BMRA)
NASDAQ: BMRA
· Real-Time Price · USD
2.89
0.04 (1.40%)
At close: Sep 24, 2025, 3:57 PM
2.87
-0.69%
After-hours: Sep 24, 2025, 04:10 PM EDT
Biomerica Revenue Breakdown
| Period Ending | Feb 29, 2024 | Nov 30, 2023 | Feb 29, 2020 |
|---|---|---|---|
| Clinical Lab Revenue | 404K | 992K | 723K |
| Clinical Lab Revenue Growth | -59.27% | +37.21% | n/a |
| Contract Manufacturing Revenue | 281K | 131K | 151K |
| Contract Manufacturing Revenue Growth | +114.50% | -13.25% | n/a |
| Physician's Office Revenue | 3K | 1K | n/a |
| Physician's Office Revenue Growth | +200.00% | n/a | n/a |
Revenue by Geography
| Period Ending | Feb 28, 2023 |
|---|---|
| Asia Revenue | 345K |
| Asia Revenue Growth | n/a |
| Europe Revenue | 301K |
| Europe Revenue Growth | n/a |
| North America Revenue | 461K |
| North America Revenue Growth | n/a |
| South America Revenue | 5K |
| South America Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.07M | 1.01M | 1.17M | 1.36M | 1.28M | 1.51M | 1.52M | 1.17M | 1.5M | 1.38M | 1.56M | 1.65M | 2.08M | 1.32M | 1.28M | 1.01M | 911.15K | 1.28M | 1.25M | 1.16M | 559.87K | 653.59K | 553.76K | 506.4K | 536.82K | 576.07K | 512.59K | 400.23K | 428.62K | 434.66K | 522.49K | 452.01K | 441.45K | 510.43K | 475.26K | 418.35K | 411.04K | 428.36K | 391.6K | 339.66K | 355.69K | 409.74K |
| Selling, General, and Administrative Revenue Growth | +5.53% | -13.73% | -13.75% | +6.00% | -14.92% | -0.85% | +29.78% | -21.64% | +8.43% | -11.35% | -5.91% | -20.52% | +57.19% | +3.17% | +26.84% | +11.02% | -28.73% | +1.88% | +7.75% | +108.01% | -14.34% | +18.03% | +9.35% | -5.67% | -6.81% | +12.38% | +28.07% | -6.62% | -1.39% | -16.81% | +15.59% | +2.39% | -13.51% | +7.40% | +13.60% | +1.78% | -4.04% | +9.39% | +15.29% | -4.51% | -13.19% | n/a |
| Research and Development Revenue | 252K | 217K | 257K | 297K | 265K | 343K | 412K | 472K | 368.86K | 392.03K | 461.94K | 361.17K | 297.04K | 457K | 618.52K | 439.86K | 586.19K | 563.22K | 586.4K | 674.69K | 661.61K | 473.28K | 404.85K | 370.47K | 408.81K | 497.1K | 381.4K | 391.78K | 483.79K | 353.56K | 272.44K | 288.58K | 348.71K | 256.72K | 300.96K | 224.25K | 206.86K | 185.27K | 230.21K | 157.99K | 171.22K | 184.63K |
| Research and Development Revenue Growth | +16.13% | -15.56% | -13.47% | +12.08% | -22.74% | -16.75% | -12.71% | +27.96% | -5.91% | -15.13% | +27.90% | +21.59% | -35.00% | -26.11% | +40.62% | -24.96% | +4.08% | -3.95% | -13.09% | +1.98% | +39.79% | +16.90% | +9.28% | -9.38% | -17.76% | +30.33% | -2.65% | -19.02% | +36.83% | +29.78% | -5.60% | -17.24% | +35.83% | -14.70% | +34.21% | +8.40% | +11.65% | -19.52% | +45.71% | -7.72% | -7.26% | n/a |